Norway· NO-ID_89D0EA55-EF57-4774-8E6F-BA237A0C6515
Perjeta
A pertuzumab product containing pertuzumab, registered in Norway by Roche Registration GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Pertuzumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FD02 (pertuzumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Pertuzumab · ATC L01FD02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Pertuzumab
- Manufacturer
- Roche Registration GmbH
- Country
- Norway (NO)
- ATC code
- L01FD02
- ATC class
- Pertuzumab
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_89D0EA55-EF57-4774-8E6F-BA237A0C6515
- no_varenummer5744231 x 14NOK 32579.7
- gtin7613326006118
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for pertuzumab.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pertuzumab · interactions on record
2 records
- 2 moderate
Most severe, free to view
- IdelalisibL01EM01moderate
- IdelalisibL01XX47moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pertuzumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPERJETAGenentech, Inc.
- SpainPERJETA 420 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONRoche Registration Gmbh
- FinlandPerjeta2care4 ApS
- BelgiumPerjeta 420 mgRoche Registration
- United KingdomPerjeta 420mg/14ml concentrate for solution for infusion vialsRoche Products Ltd
- CzechiaPERJETARoche Registration GmbH, Grenzach-Wyhlen
- IrelandPerjeta 420 mg concentrate for solution for infusionRoche Registration GmbH
- IcelandPerjetaRoche Registration GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Perjeta, Poherdy
- Liechtenstein · Perjeta, Poherdy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08e13734-856a-4993-91b5-2e057389fa6b GET /v1/drugs/08e13734-856a-4993-91b5-2e057389fa6b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Pertuzumab",
"merkevare_id": "ID_89D0EA55-EF57-4774-8E6F-BA237A0C6515",
"name_form_strength": "Perjeta kons til inf oppl 420 mg/14 ml",
"prescription_group": "C"
}See everything about pertuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.